Pennant Group, Inc.
Close on Oct 19, 2026
- Market cap
- $1.46B
- P/E (TTM)
- 45.2
- Dividend yield
- –
Earnings
Next report expected Nov 4, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | During market hours | $298.00M | $0.25 | $0.36 |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | During market hours | $285.40M | $0.24 | $0.32 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 25, 2026 | During market hours | $289.30M | $0.24 | $0.34 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | During market hours | $229.00M | $0.17 | $0.30 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 6, 2025 | During market hours | $219.50M | $0.20 | $0.27 |
| Q1 FY2025 Ended Mar 31, 2025 | May 6, 2025 | During market hours | $209.80M | $0.22 | $0.27 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | During market hours | $188.90M | $0.16 | $0.24 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | During market hours | $180.70M | $0.20 | $0.26 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 6, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 28, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EBITDAnon-GAAP | full year 2026 | $94.40M to $98.00M | New |
| adjusted earnings per diluted sharenon-GAAP | full year 2026 | $1.34 to $1.41 | New |
| adjusted EBITDA prior to NCInon-GAAP | full year | $101.50M to $105.10M | New |
| total revenue | 2026 | $1.17B to $1.19B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Pennant filed with the SEC
Pennant Reports Second Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports First Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Fourth Quarter and Fiscal Year 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Third Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
Regulation FD disclosure · EX-99.1 to Form 8-K/A
Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Second Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports First Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Fourth Quarter and Fiscal Year 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Third Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Second Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Announces Agreement to Purchase the Assets of Signature Healthcare at Home
Other events · EX-99.1 to Form 8-K
Pennant Reports First Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Third Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Second Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Pennant Group Appoints Lynette Walbom as Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.01 to Form 8-K
Pennant Reports First Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Pennant Group Appoints Barry Smith as Chairman and Brent Guerisoli as Director
Executive or director change · Regulation FD disclosure · EX-99.01 to Form 8-K
Pennant Reports Fourth Quarter 2022 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Pennant Group Announces Share Repurchase Program
Regulation FD disclosure · Other events · EX-99.01 to Form 8-K
The Pennant Group Reorganizes Executive Team
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Third Quarter 2022 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Second Quarter 2022 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Announces New Leadership Structure
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports First Quarter 2022 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Fourth Quarter and Full Year 2021 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Announces Strategic Senior Living Transactions
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Reports Third Quarter 2021 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Pennant Previews Third Quarter 2021 Results, Adjusts Guidance and Announces Earnings Release and Call Date
Results of operations · EX-99.1 to Form 8-K